WallStreetZenWallStreetZen

NASDAQ: VIVO
Meridian Bioscience Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for VIVO

Based on 1 analyst offering 12 month price targets for Meridian Bioscience Inc.
Min Forecast
$34.00+6.48%
Avg Forecast
$34.00+6.48%
Max Forecast
$34.00+6.48%

Should I buy or sell VIVO stock?

Based on 1 analyst offering ratings for Meridian Bioscience Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VIVO stock forecasts and price targets.

VIVO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
HoldDowngrades$34.00+6.48%2022-07-08

1 of 1

Forecast return on equity

Is VIVO forecast to generate an efficient return?
Company
10.41%
Industry
467.49%
Market
100.32%
VIVO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VIVO forecast to generate an efficient return on assets?
Company
8.17%
Industry
9.76%
VIVO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VIVO earnings per share forecast

What is VIVO's earnings per share in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
$0.87-12.12%

VIVO revenue forecast

What is VIVO's revenue in the next 1 years based on estimates from 2 analysts?
Avg 1 year Forecast
$304.2M-11.45%

VIVO vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
VIVO$31.93$34.00+6.48%Hold
ME$3.24$5.33+64.60%Buy
PACB$6.55$23.75+262.60%Buy
OPK$1.91$4.00+109.42%Buy
NEOG$13.75$20.00+45.45%Hold

Meridian Bioscience Stock Forecast FAQ

Is Meridian Bioscience Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: VIVO) stock is to Hold VIVO stock.

Out of 1 analyst, 0 (0%) are recommending VIVO as a Strong Buy, 0 (0%) are recommending VIVO as a Buy, 1 (100%) are recommending VIVO as a Hold, 0 (0%) are recommending VIVO as a Sell, and 0 (0%) are recommending VIVO as a Strong Sell.

If you're new to stock investing, here's how to buy Meridian Bioscience stock.

What is VIVO's earnings growth forecast for 2023-2023?

(NASDAQ: VIVO) Meridian Bioscience's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.44%.

Meridian Bioscience's earnings in 2022 is $43,411,000.

In 2023, VIVO is forecast to generate $38,060,472 in earnings, with the lowest earnings forecast at $34,998,135 and the highest earnings forecast at $40,685,332.

What is VIVO's revenue growth forecast for 2023-2023?

(NASDAQ: VIVO) Meridian Bioscience's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.15%.

Meridian Bioscience's revenue in 2022 is $343,547,000.

In 2023, VIVO is forecast to generate $13,308,040,910 in revenue, with the lowest revenue forecast at $12,468,085,665 and the highest revenue forecast at $14,147,996,155.

What is VIVO's forecast return on assets (ROA) for 2023-2023?

(NASDAQ: VIVO) forecast ROA is 8.17%, which is lower than the forecast US Diagnostics & Research industry average of 9.76%.

What is VIVO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year VIVO price target, the average VIVO price target is $34.00, with the highest VIVO stock price forecast at $34.00 and the lowest VIVO stock price forecast at $34.00.

The Wall Street analyst predicted that Meridian Bioscience's share price could reach $34.00 by Jul 8, 2023. The average Meridian Bioscience stock price prediction forecasts a potential upside of 6.48% from the current VIVO share price of $31.93.

What is VIVO's Earnings Per Share (EPS) forecast for 2023-2023?

(NASDAQ: VIVO) Meridian Bioscience's current Earnings Per Share (EPS) is $0.99. In 2023, VIVO's EPS is forecast to hit $0.87 (min: $0.80, max: $0.93).

What is VIVO's forecast return on equity (ROE) for 2023-2023?

(NASDAQ: VIVO) forecast ROE is 10.41%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.